Literature DB >> 16002396

Molecular organization of target of rapamycin complex 2.

Stephan Wullschleger1, Robbie Loewith, Wolfgang Oppliger, Michael N Hall.   

Abstract

The target of rapamycin (TOR), a highly conserved serine/threonine kinase, plays a central role in the control of eukaryotic cell growth. TOR exists in two functionally and structurally distinct complexes, TOR complex 1 (TORC1) and TOR complex 2 (TORC2). TORC1 controls cell growth via a rapamycin-sensitive signaling branch regulating translation, transcription, nutrient uptake, ribosome biogenesis, and autophagy. TORC2 controls the organization of the actin cytoskeleton through a rapamycin-insensitive signaling branch and in yeast consists of the six proteins AVO1, AVO2, AVO3, BIT61, LST8, and TOR2. Here we have focused on the characterization of TORC2. Our studies suggest that TORC2 is oligomeric, likely a TORC2-TORC2 dimer. AVO1 and AVO3 bind cooperatively to the N-terminal HEAT repeat region in TOR2 and are required for TORC2 integrity. AVO2 is a nonessential peripheral protein associated with AVO1 and AVO3. LST8 binds separately to the C-terminal kinase domain region in TOR2 and appears to modulate both the integrity and kinase activity of TORC2. TORC2 autophosphorylates sites in AVO1 and AVO3, but TORC2 kinase activity is not required for TORC2 integrity. We have demonstrated that mammalian TOR is also oligomeric. The architecture of TORC2 is discussed in the context of TORC2 assembly and regulation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16002396     DOI: 10.1074/jbc.M505553200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  102 in total

1.  Genome Wide Analysis of WD40 Proteins in Saccharomyces cerevisiae and Their Orthologs in Candida albicans.

Authors:  Buddhi Prakash Jain
Journal:  Protein J       Date:  2019-02       Impact factor: 2.371

2.  PAS kinase promotes cell survival and growth through activation of Rho1.

Authors:  Caleb M Cardon; Thomas Beck; Michael N Hall; Jared Rutter
Journal:  Sci Signal       Date:  2012-01-31       Impact factor: 8.192

3.  Conservation, duplication, and loss of the Tor signaling pathway in the fungal kingdom.

Authors:  Cecelia A Shertz; Robert J Bastidas; Wenjun Li; Joseph Heitman; Maria E Cardenas
Journal:  BMC Genomics       Date:  2010-09-23       Impact factor: 3.969

Review 4.  Transcriptional regulation in yeast during diauxic shift and stationary phase.

Authors:  Luciano Galdieri; Swati Mehrotra; Sean Yu; Ales Vancura
Journal:  OMICS       Date:  2010-09-23

Review 5.  Mechanisms regulating the protein kinases of Saccharomyces cerevisiae.

Authors:  Eric M Rubenstein; Martin C Schmidt
Journal:  Eukaryot Cell       Date:  2007-03-02

6.  TORC2 plasma membrane localization is essential for cell viability and restricted to a distinct domain.

Authors:  Doris Berchtold; Tobias C Walther
Journal:  Mol Biol Cell       Date:  2009-01-14       Impact factor: 4.138

7.  XPLN is an endogenous inhibitor of mTORC2.

Authors:  Nidhi Khanna; Yimin Fang; Mee-Sup Yoon; Jie Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

8.  Signaling events downstream of mammalian target of rapamycin complex 2 are attenuated in cells and tumors deficient for the tuberous sclerosis complex tumor suppressors.

Authors:  Jingxiang Huang; Shulin Wu; Chin-Lee Wu; Brendan D Manning
Journal:  Cancer Res       Date:  2009-07-14       Impact factor: 12.701

Review 9.  Life in the midst of scarcity: adaptations to nutrient availability in Saccharomyces cerevisiae.

Authors:  Bart Smets; Ruben Ghillebert; Pepijn De Snijder; Matteo Binda; Erwin Swinnen; Claudio De Virgilio; Joris Winderickx
Journal:  Curr Genet       Date:  2010-02       Impact factor: 3.886

10.  Third target of rapamycin complex negatively regulates development of quiescence in Trypanosoma brucei.

Authors:  Antonio Barquilla; Manuel Saldivia; Rosario Diaz; Jean-Mathieu Bart; Isabel Vidal; Enrique Calvo; Michael N Hall; Miguel Navarro
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.